| Literature DB >> 24146964 |
Huajie Luo1, Tao Yang, Xiaojie Jin, Xiuhong Pang, Jiping Li, Yongchuan Chai, Lei Li, Yi Zhang, Luping Zhang, Zhihua Zhang, Wenjing Wu, Qin Zhang, Xianting Hu, Jingwen Sun, Xuemei Jiang, Zhuping Fan, Zhiwu Huang, Hao Wu.
Abstract
Several single nucleotide polymorphisms (SNPs) of the Glutamate metabotrophic receptor 7 gene (GRM7) have recently been identified by the genome-wide association study (GWAS) as potentially playing a role in susceptibility to age-related hearing impairment (ARHI), however this has not been validated in the Han Chinese population. The aim of this study was to determine if these SNPs are also associated with ARHI in an elderly male Han Chinese population. In this case-control candidate genes association study, a total of 982 men with ARHI and 324 normal-hearing controls subjects were studied. Using K-means cluster analysis, four audiogram shape subtypes of ARHI were identified in the case group: ''flat shape (FL)'', ''sloping shape (SL)'', ''2-4 kHz abrupt loss (AL) shape'' and ''8 kHz dip (8D) shape''. Results suggested that the SNP rs11928865 (A>T) of GRM7 was significantly associated with ARHI after adjusting for non-genetic factors (p = 0.000472, OR = 1.599, 95%CI = 1.229~2.081). Furthermore, frequency of TT genotype (rs11928865) were significant higher in the SL subgroup and AL subgroup with compared to controls group (p = 9.41E-05, OR = 1.945, 95%CI = 1.393~2.715; p = 0.000109, OR = 1.915, 95%CI = 1.378~2.661 adjusted, respectively) after Bonferroni correction. However, there wasn't significant difference in the frequency of the TT genotype between cases in the FL subgroup or the 8D subgroup with when compared with controls. Results of the current study suggest that, in an elderly male Han Chinese population, GRM7 SNP rs11928865 (TT) occurs more frequently in ARHI patients with SL and AL phenotype patterns.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24146964 PMCID: PMC3795658 DOI: 10.1371/journal.pone.0077153
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Linkage disequilibrium (LD) across SNPs selected of the GRM7 gene.
The results of LD mapping were generated using Haploview software. The value for r2 between each selected SNP is presented in each box. Red boxes denote strong LD (D’= 1.0) and white boxes denote very weak LD (r2= 0.173,).
Figure 2Illustrates shape 7-,8-, 9-, 10-, 11- and 12- solutions of ARHI group audiogram patterns classified by k-means cluter analysis.
For easy comparison, all audiometric shapes are calibrated at the left most frequency (0.25 kHz). Basic audiogram shapes from seven-shape solution, appear. Three lines: the flat shape (blue solid line, yellow solid line) and 8 kHz dip (8D) shape (purple solid line), and is almost identical to 11-shape. The sloping shape group (red solid line) and brutal loss group (green dotted line) are very uniform and easy to distinguish in the 11-shape solution. In the twelve-shape solution, the new shape (black line 2) appears and was observed in a small group of 2 subjects.
Nomenclature and subgroups of audiogram 11 shapes.
| Nom of configuration | Audiogram line number | n(%) | Total n(%) |
|---|---|---|---|
| Flat shape(FL) | 7 | 66(6.72%) | 200(20.37%) |
| 9 | 134(13.65%) | ||
| 8 kHz dip (8D) shape (8D) | 5 | 91(9.27%) | 91(9.27%) |
| 2-4kHz abrupt loss shape(AL) | 4 | 68(6.92%) | 354(36.05) |
| 2 | 136(13.85%) | ||
| 3 | 94(9.57%) | ||
| 10 | 56(5.70%) | ||
| Sloping shape (SL) | 8 | 142(14.46%) | 337(34.32%) |
| 1 | 110(11.20%) | ||
| 6 | 68(6.92%) | ||
| 11 | 17(1.73%) | ||
| Total in case group | 982(100%) |
Association study between the selected taqSNPs and ARHI in Case and Control Groups.
|
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Control(n) | % | ARHI(n) | % | Control(n) | % | ARHI(n) | % | ||||
| rs11928865 | AA | 11 | 3.40% | 19 | 1.93% | A | 140 | 21.60% | 308 | 15.68% | 1.482(1.185-1.852) |
| AT | 118 | 36.42% | 270 | 27.49% | T | 508 | 78.40% | 1656 | 84.32% |
| |
| TT | 195 | 60.19% | 693 | 70.57% | |||||||
| rs11920109 | CC | 114 | 35.19% | 332 | 33.81% | C | 392 | 60.49% | 1142 | 58.15% | 1.074(0.896-1.287) |
| CT | 164 | 50.62% | 478 | 48.68% | T | 256 | 39.51% | 822 | 41.85% |
| |
| TT | 46 | 14.20% | 172 | 17.52% | |||||||
OR, odds ratio; CI, confidence interval
Association of GRM7 SNP rs11928865 in patients with different audiogram patterns of ARHI (based on the K-means cluster analysis) and in control subjects.
| Group | Genotype | P for Genotype | Allele | P for Allele | OR for T Allele (95%CI) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| AA | AT | TT | Dominant model | additive model | recessive model | A | T | |||
| minor allele | major allele | |||||||||
| Control subjects (n=324 ) | ||||||||||
| Count | 11 | 118 | 195 | 140 | 508 | |||||
| Frequency (%) | 3.40% | 36.42% | 60.19% | 21.60% | 78.40% | |||||
| All case patients(n=982) | 0.12817 | 0.00178 | 0.00051 | 0.00100 | 1.482(1.185-1.852) | |||||
| Count | 19 | 270 | 693 | 308 | 1656 | |||||
| Frequency (%) | 1.93% | 27.49% | 70.57% | 15.68% | 84.32% | |||||
| FL subgroup case patients(n=200) | 0.05169 | 0.89450 | 0.70260 | 0.66400 | 0.936(0.694-1.262) | |||||
| Count | 8 | 75 | 117 | 91 | 309 | |||||
| Frequency (%) | 4.00% | 37.50% | 58.50% | 22.75% | 77.25% | |||||
| SL subgroup case patients(n=337) | 0.18986 | 0.00058 | 0.00013 | 0.00020 | 1.722(1.291-2.296) | |||||
| Count | 6 | 81 | 250 | 93 | 581 | |||||
| Frequency (%) | 1.78% | 24.04% | 74.18% | 13.80% | 86.20% | |||||
| AL subgroup case patients(n=354) | 0.04518 | 0.00041 | 0.00017 | 0.00013 | 1.736(1.306-2.307) | |||||
| Count | 4 | 89 | 261 | 97 | 611 | |||||
| Frequency (%) | 1.13% | 25.14% | 73.73% | 13.70% | 86.30% | |||||
| 8D subgroup case patients(n=91) | 0.24810 | 0.11195 | 0.05010 | 0.04400 | 1.582(1.009-2.480) | |||||
| Count | 1 | 25 | 65 | 27 | 155 | |||||
| Frequency (%) | 1.10% | 27.47% | 71.43% | 14.84% | 85.16% | |||||
OR, odds ratio; CI, confidence interval
Logistic Regression Model: analysis of the effects of GRM7 SNP rs11928865 genotypes and nongenetic factors in case and control groups.
| Control subjects (n=324 ) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VS | |||||||||||||||
| All case patients(n=982) | AL subgroup case patients(n=354) | 8D subgroup case patients(n=91) | SL subgroup case patients(n=337) | FL subgroup case patients(n=200) | |||||||||||
| Variable | P | OR | 95%CI | P | OR | 95%CI | OR | 95%CI | P | OR | 95%CI | P | OR | 95%CI | |
| AA+AT | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| TT | 0.000472 | 1.599 | 1.229 ~ 2.081 | 0.000109 | 1.915 | 1.378 ~ 2.661 | 0.071177 | 1.607 | 0.960 ~ 2.690 | 9.41E-05 | 1.945 | 1.393 ~ 2.715 | 0.708209 | 0.933 | 0.647 ~ 1.344 |
| CO | 0.670 | 0.946 | 0.735 ~ 1.219 | 0.284 | 0.845 | 0.621 ~ 1.150 | 0.677 | 0.904 | 0.562 ~ 1.454 | 0.310 | 0.851 | 0.623 ~ 1.162 | 0.108 | 1.345 | 0.937 ~ 1.930 |
| CAD | 0.976 | 1.003 | 0.805 ~ 1.251 | 0.862 | 1.020 | 0.819 ~ 1.270 | 0.817 | 0.934 | 0.521 ~ 1.673 | 0.510 | 0.881 | 0.605 ~ 1.284 | 0.629 | 1.108 | 0.730 ~ 1.683 |
| HTN | 0.830 | 1.029 | 0.795 ~ 1.331 | 0.871 | 0.974 | 0.710 ~ 1.336 | 0.218 | 1.359 | 0.834 ~ 2.213 | 0.814 | 0.962 | 0.700 ~ 1.323 | 0.521 | 1.127 | 0.782 ~ 1.625 |
| DM | 0.348 | 1.157 | 0.853 ~ 1.569 | 0.681 | 1.081 | 0.746 ~ 1.567 | 0.578 | 0.845 | 0.467 ~ 1.530 | 0.139 | 1.319 | 0.914 ~ 1.902 | 0.534 | 1.144 | 0.749 ~ 1.748 |
| DL | 0.636 | 1.073 | 0.802 ~ 1.436 | 0.427 | 1.154 | 0.811 ~ 1.640 | 0.645 | 1.137 | 0.659 ~ 1.959 | 0.585 | 1.104 | 0.773 ~ 1.577 | 0.763 | 0.937 | 0.616 ~ 1.426 |
| CKD | 0.956 | 1.010 | 0.700 ~ 1.458 | 0.813 | 0.946 | 0.600 ~ 1.492 | 0.978 | 0.990 | 0.502 ~ 1.954 | 0.518 | 1.158 | 0.742 ~ 1.809 | 1.000 | 1.000 | 0.597 ~ 1.675 |
| COPD | 0.566 | 0.927 | 0.715 ~ 1.201 | 0.515 | 0.907 | 0.677 ~ 1.216 | 0.795 | 1.048 | 0.737 ~ 1.488 | 0.664 | 0.937 | 0.700 ~ 1.255 | 0.844 | 0.969 | 0.710 ~ 1.324 |
| Anemia | 0.934 | 0.992 | 0.815 ~ 1.206 | 0.626 | 0.953 | 0.786 ~ 1.156 | 0.874 | 0.979 | 0.755 ~ 1.270 | 0.851 | 0.982 | 0.811 ~ 1.188 | 0.542 | 1.062 | 0.875 ~ 1.290 |
| 0P | 0.706 | 0.952 | 0.736 ~ 1.231 | 0.536 | 0.906 | 0.664 ~ 1.237 | 0.415 | 1.225 | 0.752 ~ 1.995 | 0.757 | 0.952 | 0.695 ~ 1.304 | 0.661 | 1.085 | 0.753 ~ 1.564 |
| Smoking | 0.647 | 0.940 | 0.721 ~ 1.225 | 0.091 | 0.760 | 0.553 ~ 1.045 | 0.594 | 1.152 | 0.684 ~ 1.942 | 0.593 | 0.915 | 0.660 ~ 1.268 | 0.570 | 1.116 | 0.764 ~ 1.632 |
| Drinking | 0.771 | 0.960 | 0.731 ~ 1.262 | 0.485 | 0.889 | 0.638 ~ 1.237 | 0.063 | 1.732 | 0.971 ~ 3.088 | 0.300 | 0.837 | 0.597 ~ 1.173 | 0.782 | 1.057 | 0.713 ~ 1.568 |
Adjusted Odds Ratios for genotypes TT vs. AA+AT of GRM7 SNP rs11928865 for ARHI in different audiogram patterns (by Logistic Regression Analysis under the recessive mode) in case and control groups.
ORs adjusted for other clinical traits: central obesity (CO), cardiovascular disease (CAD), hypertension (HTN), diabetes mellitus (DM), dyslipidemia (DL), chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), anemia, osteoporosis (OP).